Table 2

Baseline characteristics for the monozygotic twin pairs and control pairs per disease

Monozygotic twin pairsControl pairsSignificance
(Mann-Whitney U test,
2-tailed)
DCMLVEFN811
Age, years
(median, IQR)
51.4 (24.0)49.6 (25.6)0.52
Male (pairs, %)4 (50%)3 (27%)0.16
LVEF, %
(median, IQR)
32.0 (20.0)52.3 (31.7)0.001**
LVEDDN715
Age, years
(median, IQR)
45.9 (21.1)50.4 (29.4)0.30
Male (pairs, %)3 (43%)6 (40%)0.86
LVEDD, mm
(median, IQR)
55.5 (6.3)54.7 (7.8)0.41
HCMIVSdN1114
Age, years
(median, IQR)
30.3 (29.3)48.2 (33.3)0.06
Male (pairs, %)6 (55%)10 (71%)0.93
IVSd, mm
(median, IQR)
15.5 (8.3)11.5 (10.8)0.09
LQTSQTcN2530
Age, years
(median, IQR)
26.5 (46.8)32.3 (30.3)0.13
Male (pairs, %)13 (52%)14 (47%)0.58
QTc, ms
(median, IQR)
464 (49)462 (76)0.77
  • **Significant at the <0.01 level.

  • As not all data were complete for some pairs, the number of pairs in which we could assess certain traits differs from the number of pairs mentioned in table 1.

  • DCM, dilated cardiomyopathy; HCM, hypertrophic cardiomyopathy; IVSd, diastolic interventricular septum thickness; LQTS, long QT syndrome; LVEDD, left ventricular end-diastolic dimension; LVEF, left ventricular ejection fraction; QTc, corrected QT interval.